Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Intra Cellular Therapies

Intra Cellular Therapies reported $10K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Cytokinetics CYTK:US USD 94K 0
Esperion Therapeutics ESPR:US USD 87K 12K
Halozyme Therapeutics HALO:US USD 132K 3K
Intra Cellular Therapies ITCI:US USD 10K 1000
J&J JNJ:US USD 3.12B 0
Marinus Pharmaceuticals MRNS:US USD 50K 0
Minerva Neurosciences NERV:US USD 1000 0
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NVS:US USD 842M 48M
RedHill Biopharma RDHL:US USD 2.84M 1M
Supernus Pharmaceuticals SUPN:US USD 54K 0
United Therapeutics UTHR:US USD 700K 0
Vanda Pharmaceuticals VNDA:US USD 57K 0